Results 31 to 40 of about 1,136,512 (313)

Application of optical tweezers in cardiovascular research: More than just a measuring tool

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Recent advances in the field of optical tweezer technology have shown intriguing potential for applications in cardiovascular medicine, bringing this laboratory nanomechanical instrument into the spotlight of translational medicine.
Yi Yang   +8 more
doaj   +1 more source

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study

open access: yesFrontiers in Cardiovascular Medicine, 2022
PurposeDabigatran concentrations monitoring are gaining importance of special situations, but limited data are available for the expected peak and trough levels. The hemoclot thrombin inhibitor (HTI) is dabigatran-calibrated quantitative determination of
Zhiyan Liu   +9 more
doaj   +1 more source

HIV AND CARDIOVASCULAR MEDICINE [PDF]

open access: yesHeart, 2003
As the human immunodeficiency virus (HIV) pandemic enters its third decade, the resultant acquired immunodeficiency syndrome (AIDS) is a global health crisis with approximately 36 million people affected worldwide.1,2 The disease is now the principal cause of death in young adults in many parts of the USA and Europe, and morbidity and mortality have ...
openaire   +3 more sources

e-Health in Cardiovascular Medicine [PDF]

open access: yesMedical Sciences, 2019
Cardiovascular disease (CVD), including coronary artery disease (CHD) and stroke, is the leading cause of death and disease burden globally [...]
Julie Redfern, Lis Neubeck
openaire   +4 more sources

Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundThis study aimed to compare the incidence of myocarditis in COVID-19 vaccines and in severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection groups.MethodsElectronic databases (MEDLINE, Scopus, Cochrane Central Register of ...
Navya Voleti   +3 more
doaj   +1 more source

Reforming Cardiovascular Care in the United States towards High-Quality Care at Lower Cost with Examples from Model Programs in the State of Michigan

open access: yesRambam Maimonides Medical Journal, 2014
Despite its status as a world leader in treatment innovation and medical education, a quality chasm exists in American health care. Care fragmentation and poor coordination contribute to expensive care with highly variable quality in the United States ...
Daniel Alyeshmerni   +3 more
doaj   +1 more source

Modifications in FLAP's second cytosolic loop influence 5‐LOX interaction, inhibitor binding, and leukotriene formation

open access: yesFEBS Letters, EarlyView.
The enzyme 5‐lipoxygenase (5‐LOX) catalyzes the first step in the biosynthesis of leukotrienes (LTs) involved in inflammatory pathophysiology. After cellular stimulation, 5‐LOX translocates to the nucleus, interacting with the 5‐LOX‐activating protein (FLAP) to form LTA4 from arachidonic acid (AA).
Erik Romp   +5 more
wiley   +1 more source

Consensus document on palliative care in cardiorenal patients

open access: yesFrontiers in Cardiovascular Medicine, 2023
There is an unmet need to create consensus documents on the management of cardiorenal patients since, due to the aging of the population and the rise of both pathologies, these patients are becoming more prevalent in daily clinical practice.
Clara Bonanad   +25 more
doaj   +1 more source

Evolutionary interplay between viruses and R‐loops

open access: yesFEBS Letters, EarlyView.
Viruses interact with specialized nucleic acid structures called R‐loops to influence host transcription, epigenetic states, latency, and immune evasion. This Perspective examines the roles of R‐loops in viral replication, integration, and silencing, and how viruses co‐opt or avoid these structures.
Zsolt Karányi   +4 more
wiley   +1 more source

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases

open access: yesMolecular Therapy: Nucleic Acids, 2022
Cardiovascular diseases lead the mortality and morbidity disease metrics worldwide. A multitude of chemical base modifications in ribonucleic acids (RNAs) have been linked with key events of cardiovascular diseases and metabolic disorders.
Vilbert Sikorski   +2 more
doaj  

Home - About - Disclaimer - Privacy